Journal
DRUG AND CHEMICAL TOXICOLOGY
Volume 45, Issue 1, Pages 44-51Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/01480545.2019.1658768
Keywords
Alzheimer's disease; diarylpropionitrile; hydrogen peroxide; neuroblastoma SH-SY5Y cells; oxidative stress
Funding
- Mahidol University [IRG5780009]
- Thailand Research Fund (TRF) [IRG5780009]
- Faculty of Graduate Studies, Mahidol University
Ask authors/readers for more resources
The study shows that DPN, an antioxidant selective agonist of estrogen receptor beta, can protect neuroblastoma cells from oxidative stress by attenuating various pathways involved in cell damage, indicating its potential in ameliorating neurodegenerative disorders.
Oxidative stress is implicated in pathogenesis of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases. The study demonstrates diarylpropionitrile (DPN), an antioxidant selective agonist of estrogen receptor beta, protected human neuroblastoma SH-SY5Y cells against H2O2-induced toxicity by attenuating production of reactive oxygen species, apoptosis, autophagy, NF-kappa B activation, MAPK p38, JNK and ERK 1/2 signaling pathways, and beta-site amyloid precursor protein cleaving enzyme level, but, interestingly, stimulating Akt pathway. These findings indicate the important potential of DPN to ameliorate oxidative stress-associated damage in neurodegenerative disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available